<!doctype html>
<html>
  <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="chrome=1">
    <title>Homunculus by carlcrott</title>

    <link rel="stylesheet" href="stylesheets/styles.css">
    <link rel="stylesheet" href="stylesheets/github-light.css">
    <meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no">
    <!--[if lt IE 9]>
    <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
    <![endif]-->
  </head>
  

  <body>
  <div id='huge_image'></div>  
    
    <div class="wrapper">
      <header>
        <h1>Homunculus</h1>
        <p>homunculus</p>

        <p class="view"><a href="https://github.com/carlcrott/homunculus">View the Project on GitHub <small>carlcrott/homunculus</small></a></p>


        <ul>
          <li><a href="https://github.com/carlcrott/homunculus/zipball/master">Download <strong>ZIP File</strong></a></li>
          <li><a href="https://github.com/carlcrott/homunculus/tarball/master">Download <strong>TAR Ball</strong></a></li>
          <li><a href="https://github.com/carlcrott/homunculus">View On <strong>GitHub</strong></a></li>
        </ul>
      </header>
      <section>
        <h3>The Product: </h3>

        <p>An open-source organism.</p>
        <p>
        This strain will liberate biologics manufacturing from technical debt.  We will evolve an established human line into a robust secretory 
        organism optimized for manufacture. Once developed, we will offer production services to get clients through difficult scaling and cGMP validation steps.  
        </p>

        <h3>The Plan: </h3> 

<p>
To develop the organism for manufacture of Herceptin and Rituxan, the first two biologics which will be coming off-patent soon.  

Our conservative estimate of this market is 1.4 million patients/year worldwide.  
The pharmaceutical industry is revolutionizing as biologics are becoming a dominant paradigm in treatment.  
The ease of copying, sharing, and iterating will change attitudes towards patenting IP, like it did for open-source software.  
The end result is going to be better, cheaper drugs that reach more people.  It’s our plan to be a big player in this new pharmaceutical landscape.  
</p>

<h4>
Join us in our enterprise.
</h4>
<!-- 
<h3>
<a id="support-or-contact" class="anchor" href="#support-or-contact" aria-hidden="true"><span class="octicon octicon-link"></span></a>Support or Contact</h3>

<p>Having trouble with Pages? Check out our <a href="https://help.github.com/pages">documentation</a> or <a href="https://github.com/contact">contact support</a> and we’ll help you sort it out.</p>
 -->


      </section>



      <footer>
        <p>This project is maintained by <a href="https://github.com/carlcrott">carlcrott</a></p>
        <p><small>Hosted on GitHub Pages &mdash; Theme by <a href="https://github.com/orderedlist">orderedlist</a></small></p>
      </footer>
    </div>
    <script src="javascripts/scale.fix.js"></script>
    
  </body>
</html>
